Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06862037

Development of Machine Learning Models to Predict Postoperative GERD Symptom Resolution After Laparoscopic Nissen Fundoplication

This study aims to develop machine learning models to predict postoperative gastroesophageal reflux symptom resolution after laparoscopic Nissen fundoplication using Elastic Net regression and synthetic minority oversampling technique (SMOTE).

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

20 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Korea University Anam Hospital

Seoul, 02841, South Korea

About this study

In patients with gastroesophageal reflux disease (GERD) refractory to medication or those expected to require long-term medical treatment, anti-reflux surgery (ARS), including Nissen fundoplication, has been performed. GERD is usually diagnosed as esophageal mucosal damage or pathological esophageal acid exposure. However, about 35% of patients with gastroesophageal reflux symptoms do not exhibit abnormal findings on esophagogastroduodenoscopy (EGD) and esophageal pH monitoring. Meanwhile, about 10% of patients with typical GERD symptoms and 30-50% of those with atypical GERD symptoms do not experience symptom improvement even after undergoing ARS. Therefore, the importance of predicting symptom improvement after ARS and appropriately selecting surgical candidates has been increasingly emphasized.

Though previous studies have suggested several predictors-including the length of the lower esophageal sphincter (LES), resting pressure of the LES, and bolus exposure time-to predict GERD symptom resolution after ARS, no model comprehensively integrated the results of EGD, esophageal pH monitoring, and manometry.

Elastic Net regression is a machine learning method that utilizes regularized regression analysis, combining L1 (Lasso) and L2 (Ridge) penalties. This approach makes the model relatively robust against overfitting and is suitable for datasets with a small sample size, a large number of variables, and severe multicollinearity. Synthetic minority oversampling technique (SMOTE) is a method that enhances the interpretability of the minority class in a model by oversampling minority class data using the k-nearest neighbors (k-NN) algorithm. Therefore, this study aims to develop machine learning models to predict postoperative gastroesophageal reflux symptom resolution after laparoscopic Nissen fundoplication using Elastic Net regression and SMOTE.

A total of 112 patients who underwent LNF between February 2017 to February 2023 will be included in this study. Preoperative and postoperative gastroesophageal symptoms, including heartburn and regurgitation, were evaluated using the GERD Health-Related Quality of Life (GERD-HRQL) questionnaire and the Korean version of the GERD questionnaire. Postoperative symptoms were assessed at 1, 3, 6, 9, and 12 months after surgery. Patients with more than a 70% improvement in symptoms at the last follow-up will be classified as the symptom resolution group. A total of 21 models will be developed to predict the resolution of heartburn, regurgitation, or atypical symptoms using the results of manometry, 24-hour esophageal pH monitoring, or both, with seven models for each symptom. All models will also incorporate the results of EGD. Elastic Net regression and the SMOTE method will be applied to oversample the minority class and develop the model. Model performance will be validated using 5-fold cross-validation. In addition to assessing model discrimination, calibration analysis will be performed to evaluate how well the predicted probabilities align with observed outcomes. The predictive performance of conventional predictors and possible predictors, including the length of LES, resting pressure of the LES, and bolus exposure time, will be compared with the model performance of the novel model.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with age greater than 19 years
  • patients who underwent laparoscopic Nissen fundoplication from February 2017 to February 2023
  • patients who answered the GERD-HRQL questionnaire or the Korean version of the GERD questionnaire to assess preoperative and postoperative gastroesophageal reflux symptoms
  • patients who underwent esophagogastroduodenoscopy before surgery
  • patients who underwent esophageal manometry, 24-hour esophageal pH monitoring, or both before surgery

Exclusion criteria

  • pregnant
  • patients who were lost to follow-up before 3 months after surgery

Treatment and study plan

Laparoscopic Nissen fundoplication

Procedure

Laparoscopic Nissen fundoplication (LNF) is the most commonly performed anti-reflux surgery. LNF is performed in patients with GERD refractory to medication or those expected to require long-term medical treatment. During LNF, the fundus of the stomach is mobilized and wrapped 360 degrees around the lower esophagus to reinforce the lower esophageal sphincter (LES), preventing the reflux of gastric contents into the esophagus.

Primary outcomes

  1. Model performance of novel models

    Time frame: Symptoms were assessed before surgery and at 1, 3, 6, 9, and 12 months after surgery

    A total of 21 models will be developed to predict the resolution of heartburn, regurgitation, or atypical symptoms using the results of manometry, 24-hour esophageal pH monitoring, or both, with seven models for each symptom. All models will also incorporate the results of EGD. Elastic Net regression and the SMOTE method will be applied to oversample the minority class and develop the model. Model performance including AUC, sensitivity (or recall), specificity, accuracy, precision, and F1 score will be validated using 5-fold cross-validation.

Secondary outcomes

  1. Results from calibration analysis of novel models

    Time frame: Symptoms were assessed before surgery and at 1, 3, 6, 9, and 12 months after surgery

    A total of 21 models will be developed to predict the resolution of heartburn, regurgitation, or atypical symptoms using the results of manometry, 24-hour esophageal pH monitoring, or both, with seven models for each symptom. All models will also incorporate the results of EGD. Elastic Net regression and the SMOTE method will be applied to oversample the minority class and develop the model. Calibration analysis will be performed to evaluate how well the predicted probabilities align with observed outcomes.

Other outcomes

  1. Predictive performance of conventional predictors and possible predictors

    Time frame: Symptoms were assessed before surgery and at 1, 3, 6, 9, and 12 months after surgery

    A total of 21 models will be developed to predict the resolution of heartburn, regurgitation, or atypical symptoms using the results of manometry, 24-hour esophageal pH monitoring, or both, with seven models for each symptom. All models will also incorporate the results of EGD. Elastic Net regression and the SMOTE method will be applied to oversample the minority class and develop the model. Model performance will be validated using 5-fold cross-validation. The predictive performance of conventional predictors and possible predictors, including the length of LES, resting pressure of the LES, and bolus exposure time, will be compared with the model performance of the novel model.

Sponsors and collaborators

Lead sponsor

Korea University Anam Hospital

Other

Registry information

Official study title

Development of Elastic Net Regression-SMOTE Models to Predict Postoperative Gastroesophageal Reflux Symptom Resolution After Laparoscopic Nissen Fundoplication

Important dates

Study start
2017
Primary completion
2024
Study completion
2025
First posted
Mar 6, 2025
Registry last updated
Jun 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.